Medical News

RSS

Ameritox, Ridge Diagnostics partner to develop MDDScore test

Ridge Diagnostics, Inc., a neurodiagnostic company, announced today it has entered into an exclusive agreement with Ameritox, Ltd., a leader in medication monitoring, for the license rights to its proprietary developmental blood test MDDScore, a multiple biomarker analysis for Major Depressive Disorder (MDD) for primary care and pain physicians.

6 Apr 2012

Gold nanostars can deliver drug directly to cancer cell nucleus

Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature for effective treatment.

6 Apr 2012

MEDNAX acquires Burlington Anesthesia

MEDNAX, Inc., today announced the acquisition of Burlington Anesthesia PLLC, a physician group practice that provides anesthesia services in Burlington, N.C. and Farhouch Berdjis MD Medical Corp (FBMC), a pediatric cardiology practice in Orange, Calif.

6 Apr 2012

Cancer diagnosis associated with suicide, cardiovascular death

People who are diagnosed with cancer have a markedly increased risk of suicide and cardiovascular death during the period immediately after being given the diagnosis. This has been shown in a new study from Karolinska Institutet in Sweden, published in the prestigious scientific journal The New England Journal of Medicine.

6 Apr 2012

African-Americans and Hispanics with MDD less likely to get antidepressants

African-Americans and Hispanics with major depressive disorder are less likely to get antidepressants than Caucasian patients, and Medicare and Medicaid patients are less likely to get the newest generation of antidepressants.

6 Apr 2012

Advaxis, Karolinska Institutet enter collaboration to develop cat allergy vaccine

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a research collaboration with Professor Marianne van Hage, research group leader and Head of the Clinical Immunology and Allergy Unit and Vice Head of the Department of Medicine at Karolinska Institutet in Stockholm, Sweden.

6 Apr 2012

Spectrum signs definitive agreement to acquire Allos

Spectrum Pharmaceuticals and Allos Therapeutics, Inc. today announced that they have signed a definitive agreement under which Spectrum will acquire all of the outstanding shares of Allos for $1.82 per share in cash plus one Contingent Value Right.

6 Apr 2012

Mylan seeks to overturn FDA decision on generic Provigil

Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has filed suit against the U.S. Food and Drug Administration (FDA) in the U.S. District Court for the District of Columbia seeking to overturn a decision by FDA, which awarded Teva sole 180-day exclusivity for the generic version of its affiliate Cephalon's Provigil.

6 Apr 2012

NEA Itching for a Cure 5K Walk to take place on April 28

The National Eczema Association (NEA) is proud to announce the FIRST ever walk for eczema: Itching for a Cure. The NEA Itching for a Cure 5K Walk will take place Saturday, April 28, 2012, in Asheville, North Carolina, on the University of North Carolina-Asheville campus.

6 Apr 2012

Delcath’s second generation CHEMOSAT system receives European CE Mark

Delcath Systems, Inc. today announced that the Company has received CE Mark approval for the second generation hemofiltration cartridge of the Company's proprietary Hepatic CHEMOSAT Delivery System.

6 Apr 2012

New microfluidics-based microarray can accurately detect breast cancer

One in eight women will be diagnosed with breast cancer during her lifetime. The earlier cancer is detected, the better the chance of successful treatment and long-term survival. However, early cancer diagnosis is still challenging as testing by mammography remains cumbersome, costly, and in many cases, cancer can only be detected at an advanced stage.

6 Apr 2012

Doctors continue to prescribe dangerous nifedipine drug to elderly patients

Despite the fact that nifedipine increases the risk of heart attacks and death, doctors still prescribe this immediate-release blood pressure drug to elderly patients. The Cologne-based research group led by Ingrid Schubert has now published the results of their investigation in the current issue of Deutsches -rzteblatt International.

6 Apr 2012

Care Investment Trust reports net income of $16.0M for fourth quarter 2011

Care Investment Trust Inc., a real estate investment and finance company that invests in healthcare-related real estate, today reported financial results for the fourth quarter and full year ended December 31, 2011, and announced that it has declared a quarterly dividend of $0.135 per share for the fourth quarter 2011.

6 Apr 2012

USPTO issues patent to ChromaDex’s pterostilbene

The U.S. Patent and Trademark Office has granted patent #8,133,917 pertaining to the ingredient pterostilbene, which is licensed exclusively to ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of BluScience, its new line of dietary supplements.

6 Apr 2012

Label-Free Technologies Conference to be held in Amsterdam

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the Label-Free Technologies Conference to be held in Amsterdam, the Netherlands, 1-3 November 2012.

6 Apr 2012

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

Devon Medical Products, a global medical device designer, manufacturer, and distributor, today announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) system.

6 Apr 2012

AHS announces acquisition of COMPUDATA

AdvantEdge Healthcare Solutions (AHS), one of the nation's leading providers of medical billing, practice management, and coding services for specialty physicians, hospitals, and surgery centers, announced today that it has acquired COMPUDATA, Inc., an Ohio-based medical billing company. This represents AHS' fifth acquisition since mid-2009, and expands the company's footprint in Ohio and Pennsylvania while strengthening the company's anesthesia practice customer base.

6 Apr 2012

Political cartoon: 'Vegetable Tale'

Kaiser Health News provides a fresh take on health policy developments with "Vegetable Tale" by Jen Sorensen.

6 Apr 2012

People consuming energy drinks while not exercising put themselves at risk

Researchers have found that more people are making themselves vulnerable to health problems by downing sports energy drinks that are meant to be used with intense exercise – while sitting around.

5 Apr 2012

Dentists to screen for too much alcohol intake

The UK Government is proposing that dentists should question their patients on alcohol consumption, or that dental receptionists hand out drinking questionnaires to patients to be filled in while they wait for appointments. The plans have been drawn up by dentists at Cardiff University to try to combat excessive drinking. Patients who are deemed to drink too much would be referred on to sessions with dental nurses or hygienists for advice on cutting down.

5 Apr 2012